MedPath

A Multi-Method Early Intervention Program for Inhibited and Anxious Preschoolers

Not Applicable
Completed
Conditions
Behavioral Inhibition
Anxiety
Registration Number
NCT03486860
Lead Sponsor
University of Maryland, College Park
Brief Summary

This project aims to develop and evaluate a novel early intervention program that targets the specific risk factors implicated in the development and persistence of shyness, social reticence, and withdrawal in children. The project includes a program development phase, Phase I (pilot test of full study procedures using developed treatment protocol), and Phase II (randomized controlled trial/RCT). Outcomes that will be assessed include change in child behavioral inhibition and parenting, using parent and teacher reports and observational data. Families are assessed at three time points: baseline, post-treatment (or at approximately 8 weeks for the control group), and 2 month follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria
  • Child must be attending preschool; child must score within top 15% on parent-rated Behavioral Inhibition Questionnaire; child has a biological parent with at least 50% physical custody who consents to participate
Exclusion Criteria
  • Child has a diagnosis of pervasive developmental disorder or mental retardation; child scores above clinical cutoff on Social Communication Questionnaire; child is currently receiving treatment for anxiety

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in child anxiety disorder symptomsPre-treatment (baseline), post-treatment (week 8), and 2-month follow-up

Assessed with diagnostic interviews (Preschool Age Psychiatric Assessment) with parents

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Maryland

🇺🇸

College Park, Maryland, United States

University of Maryland
🇺🇸College Park, Maryland, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.